文献速递脑血管病外科神经重症

壁面剪切应力降低通过微小RNA-29/II型转化生长因子β受体/Smad3轴激活血管紧张素II促进颅内动脉瘤蛛网膜下腔出血

Wall Shear Stress Reduction Activates Angiotensin II to Facilitate Aneurysmal Subarachnoid Hemorrhage in Intracranial Aneurysms Through MicroRNA-29/The Growth Factor-Beta Receptor Type II/Smad3 Axis.
PubMed 文献 · World Neurosurg · 2023-05-23

研究通过计算机模拟预测颅内动脉瘤相关基因及壁面剪切应力(WSS)相关基因,建立大鼠颅内动脉瘤模型,发现WSS降低与血管紧张素II(Ang II)正相关,Ang II通过抑制微小RNA-29(miR-29)上调II型转化生长因子β受体(TGFBR2)/Smad3轴促进内皮-间质转化,体内实验显示miR-29激动剂可延迟动脉瘤形成并降低蛛网膜下腔出血风险。

要点

  • WSS降低与颅内动脉瘤大鼠血管组织中Ang II水平呈正相关。
  • Ang II通过抑制miR-29上调TGFBR2/Smad3轴促进内皮-间质转化。
  • miR-29激动剂治疗可延迟大鼠颅内动脉瘤形成并降低蛛网膜下腔出血风险。

核心结论

  • WSS降低可激活Ang II、减少miR-29表达并激活TGFBR2/Smad3轴,从而促进内皮-间质转化并加速颅内动脉瘤进展。

研究设计与样本

  • 研究通过计算机模拟分析预测颅内动脉瘤相关基因及WSS相关基因,并建立大鼠颅内动脉瘤模型。
  • 从颅内动脉瘤大鼠分离血管内皮细胞,分别用miR-29模拟物/抑制剂、TGFBR2小干扰RNA/过表达TGFBR2、Ang II或血管紧张素转换酶抑制剂处理。
  • 通过流式细胞术评估内皮-间质转化,并在体内分析miR-29功能获得后颅内动脉瘤体积及蛛网膜下腔出血风险。

主要发现

  • 颅内动脉瘤大鼠载瘤动脉中WSS降低,且与血管组织中血管紧张素转换酶(ACE)和Ang II呈正相关。
  • 颅内动脉瘤大鼠血管组织中miR-29降低,ACE、Ang II和TGFBR2升高。
  • Ang II抑制miR-29,而miR-29靶向TGFBR2;TGFBR2下调伴随Smad3磷酸化抑制。
  • Ang II通过削弱miR-29对TGFBR2的抑制来增强内皮-间质转化。
  • 体内数据证实miR-29激动剂治疗延迟颅内动脉瘤形成并降低蛛网膜下腔出血风险。

关键数值与推荐

  • 颅内动脉瘤大鼠载瘤动脉中WSS降低,与血管组织中ACE和Ang II呈正相关。
  • 颅内动脉瘤大鼠血管组织中miR-29降低,ACE、Ang II和TGFBR2升高。
  • miR-29靶向TGFBR2,TGFBR2下调伴随Smad3磷酸化抑制。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We tried to broaden our knowledge of the possible role of wall shear stress (WSS) in the occurrence of intracranial aneurysms (IAs). METHODS: Genes implicated in IAs and genes related to WSS were predicted through in silico analysis. Rat models of IAs were established, in which the expression patterns of angiotensin II (Ang II) were characterized, and WSS was assessed. Vascular endothelial cells isolated from rats bearing IAs were treated with microRNA-29 (miR-29) mimic/inhibitor, small interfering RNA-TGF-β receptor type II (TGFBR2)/overexpressed TGFBR2, Ang II, or angiotensin-converting enzyme (ACE) inhibitor. Then, the endothelial-to-mesenchymal transition (EndMT) was evaluated by flow cytometry. Finally, the volume of IAs and risk of subarachnoid hemorrhage were analyzed in vivo in response to miR-29 gain of function. RESULTS: WSS was decreased in the IA bearing arteries, which showed a positive correlation with ACE and Ang II in the vascular tissues of IA rats. Reduced miR-29 and increased ACE, Ang II, and TGFBR2 were detected in the vascular tissues of IA rats. Ang II inhibited miR-29, which targeted TGFBR2. Downregulated TGFBR2 was accompanied by suppression of Smad3 phosphorylation. Through impairing miR-29-dependent inhibition of TGFBR2, Ang II enhanced EndMT. In vivo data confirmed that treatment of miR-29 agomir delayed the formation of IA and decreased the risk of subarachnoid hemorrhage. CONCLUSIONS: The current study provided evidence that WSS reduction could activate Ang II, reduce miR-29 expression, and activate the TGFBR2/Smad3 axis, thus promoting EndMT and accelerating the progression of IAs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Cheng L, Huang Y, Yao H, et al. Wall Shear Stress Reduction Activates Angiotensin II to Facilitate Aneurysmal Subarachnoid Hemorrhage in Intracranial Aneurysms Through MicroRNA-29/The Growth Factor-Beta Receptor Type II/Smad3 Axis. World Neurosurg. 2023. PMID: 37230243. doi:10.1016/j.wneu.2023.05.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。